BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2454896)

  • 1. Value correlation of alpha-fetoprotein and human chorionic gonadotropin with the results of lymphadenectomy in non-seminomatous testicular tumours.
    Kausitz J; Hupka S; Ondrus D; Michalko J
    Int Urol Nephrol; 1988; 20(2):147-9. PubMed ID: 2454896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
    Lange PH; McIntire KR; Waldmann TA; Hakala TR; Fraley EE
    J Urol; 1977 Oct; 118(4):593-6. PubMed ID: 72163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor markers in testicular cancer.
    Catalona WJ
    Urol Clin North Am; 1979 Oct; 6(3):613-28. PubMed ID: 92089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic progress in testicular carcinoma].
    Aiginger P; Kolbe H; Kühböck J; Spona J
    Acta Med Austriaca; 1978; 5(4-5):159-61. PubMed ID: 91300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with serum alpha-fetoprotein and human chorionic gonadotropin in non-seminomatous testicular tumors.
    Fowler JE; Taylor G; Blom J; Stutzman RE
    J Urol; 1980 Sep; 124(3):365-8. PubMed ID: 6159485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum alpha fetoprotein and human chorionic gonadotropin in the diagnosis and management of nonseminomatous germ-cell testicular cancer.
    Lange PH; McIntire KR; Waldmann TA; Hakala TR; Fraley EE
    N Engl J Med; 1976 Nov; 295(22):1237-40. PubMed ID: 62281
    [No Abstract]   [Full Text] [Related]  

  • 7. The value of alpha-fetoprotein and beta-human chorionic gonadotrophin in the management of testicular tumours.
    Narayana AS; Loening S; Culp DA
    Br J Urol; 1978 Dec; 50(7):605-8. PubMed ID: 88986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum estradiol as a tumour marker for non-seminomatous germinal cell tumours (NSGCT) of the testis.
    Uysal Z; Bakkaloğlu M
    Int Urol Nephrol; 1987; 19(4):415-8. PubMed ID: 2448261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tumor marker diagnosis in non-seminomatous testicular tumors using human chorionic gonadotropin (HCG) and alpha fetoprotein (AFP)].
    Boewer C; Nawka S; Fleck H; Uibel M; Immer U; Schmidt HE; Herzmann H; Pilgrim G; Ziegenbein R
    Z Urol Nephrol; 1985 Feb; 78(2):77-86. PubMed ID: 2581393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A graphical method to analyze serum tumor marker decay in nonseminomatous testis tumors.
    Lo RK; Johnson DE
    J Urol; 1984 May; 131(5):896-8. PubMed ID: 6200617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring of patients with non-seminomatous germ cell tumors of the testis by determination of alpha-fetoprotein and beta-human chorionic gonadotropin levels and by computed tomography.
    Kausitz J; Ondrus D; Belan V; Matoska J
    Neoplasma; 1992; 39(6):357-61. PubMed ID: 1283444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of basic fetoprotein in testicular cancer.
    Harada K; Morishita S; Itani A; Nagata H; Hamami G; Ishii M; Kamidono S; Ishigami J
    J Urol; 1987 Nov; 138(5):1178-80. PubMed ID: 2444719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testicular germ-cell neoplasms: recent advances in diagnosis and therapy.
    Ann Intern Med; 1979 Mar; 90(3):373-85. PubMed ID: 85422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of radioimmunoassay of human chorionic gonadotropin and alpha fetoprotein in nonseminomatous germ cell tumors of the testis.
    Kausitz J; Hupka S; Cerný V; Bohunický L; Korec S
    Neoplasma; 1980; 27(3):321-7. PubMed ID: 6161314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
    Lange PH
    Natl Cancer Inst Monogr; 1978 Dec; (49):215-7. PubMed ID: 86163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum alpha-fetoprotein and human chorionic gonadotropin in patients with seminoma.
    Lange PH; Nochomovitz LE; Rosai J; Fraley EE; Kennedy BJ; Bosl G; Brisbane J; Catalona WJ; Cochran JS; Comisarow RH; Cummings KB; deKernion JB; Einhorn LH; Hakala TR; Jewett M; Moore MR; Scardino PT; Streitz JM
    J Urol; 1980 Oct; 124(4):472-8. PubMed ID: 6158584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue alpha-fetoprotein and human chorionic gonadotrophin in non-seminomatous testicular tumours. A comparative study with serum levels.
    Altug MU; Akdas A; Ruacan S; Ozen AH; Remzi D
    Br J Urol; 1987 May; 59(5):458-62. PubMed ID: 2439163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the radioimmunoassay of serum alpha-fetoprotein and human chorionic gonadotropin in the intensive chemotherapy and surgery of metastatic testicular tumors.
    Javadpour N; McIntire KR; Waldmann TA; Scardino PT; Bergman S; Anderson T
    J Urol; 1978 Jun; 119(6):759-62. PubMed ID: 77918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum alpha-fetoprotein and human chorionic gonadotropin in the treatment of patients with testicular tumors.
    Lange PH; Fraley EE
    Urol Clin North Am; 1977 Oct; 4(3):393-406. PubMed ID: 76357
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnostic value of tumour marker regression models in stage 1 marker-positive testicular cancer.
    May M; Helke C; Nitzke T; Seehafer M; Vogler H; Hoschke B
    Urol Int; 2004; 73(4):329-36. PubMed ID: 15604578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.